Dual effects of N6-methyladenosine on cancer progression and immunotherapy
Open Access
- 1 June 2021
- journal article
- review article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 24, 25-39
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81872149)
- National Natural Science Foundation of China (81972706)
- National Natural Science Foundation of China (82072904)
- Harbin Medical University Cancer Hospital (102017-02)
This publication has 159 references indexed in Scilit:
- ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse FertilityMolecular Cell, 2013
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seqNature, 2012
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTONature Chemical Biology, 2011
- Normalization of the Vasculature for Treatment of Cancer and Other DiseasesPhysiological Reviews, 2011
- Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF-κB/IL-8 Pathway that Drives Tumor AngiogenesisCancer Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in miceJournal of Clinical Investigation, 2008
- Enhancement of Glucose Transporter Expression of Brain Endothelial Cells by Vascular Endothelial Growth Factor Derived from Glioma Exposed to HypoxiaMolecular Pharmacology, 2008
- Biochemical Function of Female-Lethal (2)D/Wilms' Tumor Suppressor-1-associated Proteins in Alternative Pre-mRNA SplicingJournal of Biological Chemistry, 2003
- The Hallmarks of CancerCell, 2000